PTCT (STOCKS)
PTC Therapeutics, Inc.
$71.970000
-0.670000 (-0.92%)
Prev close: $72.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Matthew B. Klein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,408.80M
- Employees
- 939
- P/E (TTM)
- -122.33
- P/B (TTM)
- -36.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.92 | $0.43 | +0.4948 | +116.37% |
|
Mar 2026 (Q1)
|
$-0.03 | $-0.48 | +0.4499 | +93.75% |
|
Dec 2025 (Q4)
|
$-1.67 | $0.04 | -1.7083 | -4,460.31% |
|
Sep 2025 (Q3)
|
$0.20 | $-1.40 | +1.5954 | +114.33% |
Financial Statements
| Revenues | $1.01B |
| Benefits Costs and Expenses | $1.08B |
| Costs And Expenses | $1.08B |
| Operating Expenses | $883.15M |
| Selling, General, and Administrative Expenses | $347.73M |
| Research and Development | $433.31M |
| Other Operating Expenses | $102.11M |
| Operating Income/Loss | $125.60M |
| Income/Loss From Continuing Operations After Tax | -$38.38M |
| Income/Loss From Continuing Operations Before Tax | -$67.07M |
| Income Tax Expense/Benefit | -$28.69M |
| Net Income/Loss | -$38.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.65 |
| Diluted Earnings Per Share | -$0.57 |
| Basic Average Shares | 162,128,179 |
| Diluted Average Shares | 180,351,409 |
| Assets | $3.25B |
| Current Assets | $2.62B |
| Accounts Receivable | $239.04M |
| Inventory | $91.35M |
| Other Current Assets | $2.29B |
| Noncurrent Assets | $633.12M |
| Fixed Assets | $51.49M |
| Intangible Assets | $402.93M |
| Other Non-current Assets | $178.71M |
| Liabilities | $3.42B |
| Current Liabilities | $771.07M |
| Accounts Payable | $40.45M |
| Wages | $39.30M |
| Other Current Liabilities | $691.32M |
| Noncurrent Liabilities | $2.64B |
| Equity | -$165.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$165.36M |
| Liabilities And Equity | $3.25B |
| Net Cash Flow From Operating Activities | -$30.50M |
| Net Cash Flow From Operating Activities, Continuing | -$30.50M |
| Net Cash Flow From Investing Activities | -$471.91M |
| Net Cash Flow From Investing Activities, Continuing | -$471.91M |
| Net Cash Flow From Financing Activities | $536.00M |
| Net Cash Flow From Financing Activities, Continuing | $536.00M |
| Net Cash Flow | $33.59M |
| Net Cash Flow, Continuing | $33.59M |
| Comprehensive Income/Loss | -$39.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.72M |
| Other Comprehensive Income/Loss | -$39.72M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.34M |